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The association of newly synthesized vesicular stomatitis virus proteins into
nucleocapsid structures was examined in a cell-free system that supports concur-
rent viral protein synthesis, transcription, and RNA replication. The vesicular
stomatitis virus proteins synthesized by this system associated with the newly
replicated RNA to form structures that banded in CsCl gradients with marker
nucleocapsids. In reactions lacking nucleocapsid templates to program RNA
synthesis, the newly synthesized proteins did not associate into nucleocapsid
structures. The newly synthesized proteins associated with nucleocapsids were
analyzed by electrophoresis on polyacrylamide gels containing sodium dodecyl
sulfate after separation from non-associated proteins by chromatography on Bio-
Gel A1SM agarose columns. The results of this analysis showed that newly
synthesized L, NS, and N proteins associated into nucleocapsids in the in vitro
system. In addition, a small amount of newly synthesized M protein was stably
bound to the nucleocapsids. The molar ratio of the associated, newly synthesized
proteins was 2:350:1,000:10 (L:NS:N:M). More than 90% of the newly synthe-
sized NS protein that associated with nucleocapsids in vitro was of the NS2
subspecies, as assayed by DEAE-cellulose column chromatography. The stability
of the association of the newly synthesized proteins with nucleocapsids in the
system mimicked that of the association of viral proteins with nucleocapsids from
infected cells as measured by salt sensitivity. These data indicate that nucleocap-
sids were assembled from newly synthesized proteins within our in vitro system
and that the molar ratio of assembled proteins was similar to that observed for
virion nucleocapsids.
The nucleocapsid of vesicular stomatitis virus
(VSV) consists of a negative-stranded RNA
genome (molecular weight, 4 x 106) and three
virus-specified proteins: (i) N, the major nucleo-
capsid protein (ii) NS, a phosphoprotein, and
(iii) L, a component of the polymerase (8, 19). N
is the most abundant protein of the VSV nucleo-
capsid (1,000 to 2,000 copies per genome) (1, 2,
20), and its association with the genome along
with NS and L proteins renders the RNA resis-
tant to RNases. Mellon and Emerson (16) have
shown that the L protein requires the phospho-
protein NS to associate with the N protein-
coated RNA genome.
The VSV nucleocapsid serves as the template
for two distinct RNA synthetic processes which
differ in their requirement for protein synthesis.
Transcription of the VSV genome to yield leader
and the five monocistronic mRNAs can occur in
infected cells in the absence of protein synthesis
(13, 28). Replication of the genome to produce
full-length negative-stranded RNA, however, is
a process that is dependent on concurrent pro-
tein synthesis (22, 28). It is not known which of
the virus-specified protein(s) are required for
replication and whether the requirement is for
catalytic or stoichiometric amounts of these
proteins.
To examine the protein requirement for VSV
RNA synthesis, we developed a defined in vitro
system which carries out the synthesis of both
VSV negative-stranded genome RNA and the
five viral mRNAs (6, 7). The system consists of
(i) VSV intracellular nucleocapsids to serve as
templates for RNA synthesis, (ii) a micrococcal
nuclease-treated reticulocyte lysate, and (iii) pu-
rified VSV mRNAs to program protein synthe-
sis. The synthesis of VSV negative-stranded,
genomic-size RNA in the system is dependent
on the level of concurrent protein synthesis. The
negative-stranded RNA products synthesized in
this in vitro reaction band in CsCl at the same
buoyant density as nucleocapsids synthesized in
vivo, and they are at least partially resistant to
digestion by RNase (7). These two results indi-
cate that the newly synthesized negative-strand-
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ed RNA is not present as a naked RNA molecule
and suggest that the newly synthesized viral
proteins required to obtain negative-stranded
RNA synthesis may be able to associate with the
RNA to form nucleocapsid structures de novo.
In the work described here, we investigated
the possibility that the viral proteins synthesized
concurrently with RNA replication in the in
vitro system can associate into nucleocapsid
structures. The results presented show that the
newly synthesized proteins N, NS, and L asso-
ciate to form structures which have the same
stability characteristics and protein components
as nucleocapsids synthesized in vivo. We con-
clude that in this system, VSV nucleocapsid
assembly occurs in vitro with newly synthesized
proteins.
MATERIALS AND METHODS
Cell culture and virus. Baby hamster kidney cells
(BHK-21/13) were maintained in Eagle minimal essen-
tial medium containing 5% heat-inactivated calf se-
rum. VSV (Indiana serotype) was propagated in BHK
cells as described previously (28). Cells were infected
at 2 to 4 PFU/cell, maintained in the presence of 4 ,ug
of actinomycin D per ml, and harvested at 5 to 6 h
postinfection for isolation of VSV mRNA or intracel-
lular nucleocapsids.
Components of in vitro replication system. The com-
ponents of the replication system have been described
by Davis and Wertz (7). VSV mRNAs used to program
in vitro protein synthesis were recovered from infect-
ed cells by centrifugation of cytoplasmic extracts on
CsCl gradients (7). The preparation of intracellular
nucleocapsids as templates for RNA synthesis has
been described (7). Briefly, after disruption of infected
cells by Dounce homogenization, cellular debris was
pelleted by centrifugation at 10,000 rpm for 10 min at
4°C in a Sorvall SS34 rotor. The supernatant was
overlaid onto 3-ml 15 to 30% sucrose gradients in a
buffer of 3 mM Tris-hydrochloride (pH 8.1)-3 mM
magnesium acetate-66 mM NH4Cl-14 mM KCl-2 mM
dithioerythritol (DTE) and centrifuged in an Beckman
SW50.1 rotor at 45,000 rpm for 2 h at 4°C. Nucleocap-
sid-containing pellets were resuspended in 10mM N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(HEPES) (pH 7.7)-2 mM DTE-10% glycerol at a
concentration representing 106 infected cells per ,u.
Reactions were carried out in a final volume of 50 jtl
and contained 70% by volume micrococcal nuclease-
treated rabbit reticulocyte lysate (7), approximately 5
,ug of VSV mRNAs, and 12% by volume intracellular
nucleocapsids. In addition, each reaction contained 50
mM HEPES (pH 7.7), 10 mM creatine phosphate, 1
mM ATP, 0.6 mM each CTP and GTP, 0.1 mM UTP,
0.05 mM each of the 20 amino acids, except for
methionine, which was 12.5 ,uM, 2 mM magnesium
acetate, 2 mM DTE, 66 mM NH4Cl, 14 mM potassium
acetate, 2 p.g of rabbit liver tRNA, and 50 ,uCi of
[35S]methionine. Reaction mixtures were incubated
for 90 min at 30°C. Incorporation of [35S]methionine
into protein was assayed by counting radioactivity
present in trichloroacetic acid (TCA) precipitates of 2-
,ul samples removed during incubation. Precipitates
were heated to 85°C for 15 min to hydrolyze tRNAs
labeled with [35S]methionine.
Salt-detergent treatment and colunm chromatogra-
phy of nucleocapsids. Samples for analysis by molecu-
lar exclusion column chromatography were prepared
in the following manner. Reaction mixtures were dilut-
ed to 500 ,ul with column buffer (10 mM HEPES, 2 mM
MgCI2, 2 mM DTE, 66 mM NH4Cl, 14 mM potassium
acetate [pH 7.6]) and adjusted to 0.5% Nonidet P40
(NP-40). Alternatively, samples were diluted with 250
,ul of water and an equal volume of either 2x LSS
buffer (0.864 M NaCl, 18.7% glycerol, 1.2 mM DTh,
3.74% Triton X-100) or 2x HSS buffer (1.44 M NaCl,
18.7% glycerol, 1.2 mM DTE, 3.74% Triton X-100)
and then incubated at 3700 for 45 min. The samples
were applied directly to a Bio-Gel A1SM column (0.9
by 60 cm) equilibrated with column buffer. Chroma-
tography was performed with column buffer at a flow
rate of 10 ml/h. Fractions (1 ml each) were collected,
and 35-,u portions were assayed by counting radioac-
tivity present in TCA precipitates.
Electrophoresis and densitometry. 3H- or 15S-labeled
proteins were analyzed by electrophoresis on sodium
dodecyl sulfate (SDS)-containing polyacrylamide gels
as described by Laemmli and Faure (15). The resolv-
ing and stacking gels were of 10%o and 3 or 5%
acrylamide, respectively. Alternatively, radiolabeled
proteins were analyzed by electrophoresis on 10%
polyacrylamide gels containing 7 M urea and 0.1%
SDS by the method of Kingsford and Emerson (14).
After electrophoresis, gels were impregnated with 2,5-
diphenyloxazole (PPO), dried, and exposed to pre-
flashed Kodak XAR-5 or Cronex 4 film (27). In some
cases, resultant fluorograms were scanned at 632.8
mm to quantitate the intensity of bands with an LKB
2202 Ultrascan densitometer interfaced with an Apple
II computer.
CsCI centrifugation. Products of the replication sys-
tem were analyzed on 20 to 40% (wt/wt) CsCl gradi-
ents as described by Davis and Wertz (7). Samples (5
to 10 ,ll) taken from reaction mixtures were treated
with 0.5% NP-40 before being overlaid onto CsCl
gradients. The position of the nucleocapsids in the
gradients was detected by visual observation. In some
cases, fractions were desalted in the following manner.
A 5-ml disposable polypropylene tube was bottom
punctured and filled to a packed volume of 4 ml with
Sepharose 6B over a layer of glass wool. After the
application of 0.5 ml of sample to the column, the tube
was placed in a 15-ml Corex tube and centrifuged at
100 x g in a Sorvall SS34 rotor for 2 min. The sample
which eluted into the Corex tube was checked for the
absence of salt by refractometry.
NS protein analysis. Reaction mixtures were diluted
to a total of 5 ml with 10 mM Tris-hydrochloride (pH
7.2) and centrifuged at 47,500 rpm in a Beckman
SW50.1 rotor for 75 min at 4°C to pellet nucleocapsids.
The nucleocapsids were resuspended in 1.0 ml of 2x
HSS buffer diluted with an equal volume of 10 mM
Tris-hydrochloride (pH 7.2) and incubated at 37°C for
45 to 60 min. After dilution of the sample to 5 ml with
10 mM Tris-hydrochloride (pH 7.2), the nucleocapsids
were pelleted again. The NS-containing supernatant
(nucleocapsid-associated NS) was diluted with 10 mM
Tris-hydrochloride (pH 7.2) to a final concentration of
0.1 M NaCl or less and chromatographed on Whatman
CF-11 phosphocellulose columns (1.5 by 3.75 cm) as
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described by Kingsford and Emerson (14). The flow-
through fraction was subsequently analyzed by
DEAE-cellulose (Whatman DE52) column chromatog-
raphy as follows. NS preparations applied to DEAE
columns (45 by 0.9 cm) were washed with 20 ml of 0.1
M NaCl in DEAE column buffer (0.2% Triton X-100,
0.19 mM DTE, 10 mM Tris-hydrochloride [pH 7.2])
before eluting with a linear gradient of 0.22 to 0.35 M
NaCl in DEAE column buffer at a flow rate of 12 ml/h.
The position at which NS1 and NS2 eluted from the
column was ascertained by analysis of the chromato-
graphic profile of 32P-labeled NS protein prepared
from virions by using HSS buffer.
RESULTS
Analysis of protein products by centrifugation
in CsCI. The initial analysis of the products
synthesized in the VSV replication system sug-
gested that the negative-stranded RNAs pro-
duced in the system were in the form of RNA-
protein complexes (7). The RNAs were partially
RNase resistant, and they banded in CsCl gradi-
ents at a density of 1.3 g/cm3, the same position
as nucleocapsids isolated from infected cells.
These data indicated that the negative-stranded
RNA synthesized in the system was associated
with protein. Thus, we investigated the possibili-
ty that the VSV proteins synthesized concur-
rently with the RNA were associating to form
nucleocapsid structures. Specifically, we de-
signed experiments to demonstrate whether or
not (i) newly synthesized proteins associated
into structures that were stable in CsCl and (ii)
these structures cobanded in CsCl gradients
with marker nucleocapsids.
The possible association of 35S-labeled pro-
teins into nucleocapsid structures in the in vitro
replication system was analyzed initially by cen-
trifugation of products in 20 to 40% CsCl gradi-
ents. From 10 to 30% of the total 35S-labeled
proteins synthesized in the system banded in the
CsCl gradient exactly at the position of the
nucleocapsid marker (Fig. 1, top). Previous
work has shown that this is also the position at
which all negative-stranded VSV RNA synthe-
sized in the system bands in CsCl (7). The VSV-
specific proteins synthesized in reactions that
lacked nucleocapsid templates (and hence were
not synthesizing RNA) did not band in CsCl
gradients at this position, but were present pre-
dominantly in the top one-half of the gradients
(Fig. 1, bottom). These data showed (i) that the
proteins synthesized in reactions containing nu-
cleocapsid templates associated into structures
that had the same buoyant density as nucleocap-
sids produced in vivo and (ii) that the VSV
proteins synthesized in reactions lacking nucleo-
capsid templates did not form structures that
banded at the position of nucleocapsids.
To test the possibility that the newly synthe-
sized proteins associated with preexisting nu-
cleocapsid templates, proteins were synthesized
in a reaction lacking templates; afterwards, tem-
plates were added, and the reaction mixture was
incubated on ice for 30 min. Analysis of the
products by CsCl gradient centrifugation (Fig. 1,
bottom) showed that little newly synthesized
protein banded at the position of nucleocapsids.
This result suggested that the association of 35S-
labeled proteins with nucleocapsids in the sys-
tem did not represent the nonspecific aggrega-

















FIG. 1. Analysis of 35S-labeled proteins by centrif-
ugation in CsCl. Reaction mixtures which did (upper
panel) or did not (lower panel [0]) contain nucleocap-
sid templates were incubated for 90 min at 300C.
Samples (7 ,ul) of each reaction mixture were treated
with 0.5% NP-40 and analyzed by centrifugation in
gradients of 20 to 40o CsCl (wt/wt) for 16 h at 33,000
rpm in a Beckman SW40 rotor at 40C (7). After
fractionation, portions (35 Ill) of each fraction (0.5 ml)
were precipitated with TCA and assayed for radioac-
tivity. The bottom of each gradient is to the right, and
the position of banded nucleocapsids is denoted by an
arrow. In a separate experiment, after incubation for
60 min of a standard reaction mixture lacking intracel-
lular nucleocapsid templates, nucleocapsids were add-
ed to the reaction mixture, and incubation was contin-
ued for an additional 30 min at 0°C. A sample of the
reaction mixture was then treated with NP-40, and the
35S-labeled products were analyzed by CsCl gradient
centrifugation (lower panel [0]) as described above.
v
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The total 35S-labeled protein synthesized in
the in vitro system and the fraction that banded
in the CsCl gradient at the position of nucleocap-
sids were analyzed by electrophoresis in a 10%
polyacrylamide gel (Fig. 2). The results show
that although all five of the VSV proteins were
synthesized in the in vitro system, only the VSV
N protein was observed to band at the position
of the marker nucleocapsids. This result is iden-
tical to that obtained with nucleocapsids made in
vivo, for which it has been shown that the high
concentration of salt present in CsCl gradients
dissociates the less tightly bound NS and L
proteins from the nucleocapsids (18).
In summary, these data demonstrate (i) that
newly synthesized N protein is able to assemble
into structures that coband with nucleocapsids
in CsCl gradients, (ii) that the association of
newly synthesized N protein with nucleocapsids
in vitro is as stable in high concentrations of salt
as the association of N protein with nucleocap-
sids made in infected cells, (iii) that the newly
synthesized proteins by themselves are not able
to aggregate into structures that band at the
position of marker nucleocapsids, and (iv) that
proteins do not associate with preexisting nu-
cleocapsids in the absence of RNA synthesis
into structures that are stable to high concentra-
tions of salt. These results, taken together with
the finding that newly synthesized negative-
stranded RNA is RNase resistant and bands at
the density of nucleocapsids in CsCl gradients,
indicate that nucleocapsids are being formed de
novo in the replication system.
Isolation of nucleocapsids by molecular exclu-
sion chromatography. Having demonstrated that
N protein could associate to form stable struc-
tures that cobanded with nucleocapsids, we
wished to determine whether these structures
contained the full complement of nucleocapsid
proteins. Since CsCl dissociates all but N pro-
tein from nucleocapsids, an alternative method
of isolating these structures was developed. The
use of column chromatography for analysis of
nucleocapsids was advantageous because it did
not require the high osmotic pressures or salt
concentrations of sucrose or CsCl gradients. For
analysis of VSV nucleocapsids, a column con-
taining a matrix of Bio-Gel A1SM agarose,
which has a molecular exclusion limit of 1.5 x
107 daltons, was used. It was expected that VSV
nucleocapsids would elute in the void volume,
since their size exceeds 108 daltons (based on
the number and sizes of proteins estimated to be
associated with the VSV nucleocapsid [2] and
the size of the genome). In contrast, VSV
mRNAs, mRNA-protein complexes, and all of
the VSV proteins should be included in the
column matrix.
Several experiments were performed to test
2
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FIG. 2. Electrophoresis of "S-labeled proteins as-
sociated with nucleocapsids. "S-labeled proteins
banding at the position of nucleocapsids in a CsCl
gradient (Fig. 1) were desalted and then analyzed by
electrophoresis on a 10% polyacrylamide gel contain-
ing SDS (15). The gel was impregnated with PPO,
dried, and exposed to preflashed Kodak XAR-5 film
(27). The fluorogram shows "5S-labeled proteins asso-
ciated with nucleocapsids (lane 1) versus "5S-labeled
proteins applied to the gradient (lane 2).
the predictions that (i) nucleocapsids would
elute in the void volume of the column and (ii) no
free proteins or mRNA-protein complexes
would elute in the void volume, but rather would
be included by the column matrix. To test the
hypothesis that nucleocapsids would elute in the
void volume, a sample of the peak fractions from
a CsCl gradient containing 5S-labeled protein
associated with nucleocapsids synthesized in
vitro was chromatographed on a Bio-Gel A15M
column. The profile of material eluting from the
column is shown in Fig. 3. The 3 S-labeled
nucleocapsids eluted as a single peak at the
position of the void volume, which contained
approximately 100% of the material applied to
the column. Similarly, when intracellular nu-
cleocapsids synthesized in vivo in the presence
of 14C-labeled amino acids were applied to the
column, essentially all radioactive material elut-
ed in the void volume. These data demonstrated
that VSV nucleocapsids are not included by the
Bio-Gel A15M column, but rather elute entirely
in the void volume as a single peak.
To test where free proteins and viral mRNA-
protein complexes eluted from the Bio-Gel
A15M column, 35S-labeled proteins produced in
a reaction mixture to which no nucleocapsid
templates had been added were chromato-
graphed on the column. The results are present-
ed in Fig. 3 and show that less than 5% of the
35S-labeled material recovered from the column
eluted at the position of the nucleocapsids. Anal-
J. VIROL.




FIG. 3. Isolation of VSV nucleocapsids by molecu-
lar exclusion chromatography. CsCl gradient fractions
containing 3"S-labeled nucleocapsid material were
chromatographed on a Bio-Gel A15M agarose column
(0). Seven microliters of a reaction mixture containing
no nucleocapsid templates was chromatographed on
the column (0). Samples (35 Ill) of each 1.2-ml column
fraction were assayed for radioactivity present in
TCA-precipitable material. The position at which
marker nucleocapsids eluted is denoted by the arrow.
ysis of the small amount of 35S-labeled protein
which eluted in the void volume by polyacryl-
amide gel electrophoresis indicated that minor
amounts of all of the VSV proteins were present
(data not shown). These data demonstrate that
the Bio-Gel A1SM column provides a useful
method for the separation of nucleocapsids from
non-associated protein. Therefore, this tech-
nique was used in subsequent experiments to
separate nucleocapsids and their associated pro-
teins from non-associated proteins.
Analysis of 35S-labeled proteins associated with
nucleocapsids. 35S-labeled proteins associated
with nucleocapsids produced in the replication
system were separated from non-associated pro-
teins by molecular exclusion column chromatog-
raphy as described above. Samples of reaction
mixtures in which proteins were labeled with
[35S]methionine were treated with 0.5% NP-40
before chromatography on Bio-Gel A15M col-
umns. A representative profile of radioactivity
eluting from the column is shown in Fig. 4. This
and other similar experiments indicate that 40 to
60% of the 35S-labeled protein recovered from
the column eluted in the void volume and there-
fore was associated with nucleocapsids. Thus, a
significant percentage of the total 35S-labeled
protein synthesized in vitro associates with nu-
cleocapsids in this replication system.
Experiments were done to test whether the
3S-labeled proteins eluting with the nucleocap-
sids could be a product of overloading of the
Bio-Gel A15M column. Samples of the column
fractions containing 35S-labeled nucleocapsid
material were passed back through the Bio-Gel
AlSM column. Only a single peak of 35S-labeled
protein was found to elute from the column
under these conditions, and this was at the
position of the void volume (data not shown).
Therefore, the conditions used here for chroma-
tography did not overload the column.
The 35S-labeled proteins associated with nu-
cleocapsids and isolated by molecular exclusion
chromatography were analyzed by electrophore-
sis on 10% polyacrylamide gels containing SDS.
A fluorogram of a gel from a representative
experiment is shown in Fig. 5. The 35S-labeled
VSV proteins L, NS, and N synthesized in the
replication system were associated with the nu-
cleocapsids (lane 2). These three proteins are
also components of intracellular nucleocapsids
synthesized in vivo (25). Thus, these data pro-
vide evidence that the viral proteins synthesized
in this system assembled into structures contain-
ing the same viral proteins as nucleocapsids
made in vivo. In addition to NS, N, and L
proteins, a small amount of M protein was also
associated with the nucleocapsids isolated from
our replication system. The quantitation of these
proteins is described below.
Analysis of NS protein associated with nucleo-
capsids in vitro. The NS protein contained in
virion nucleocapsids can be dissociated by treat-
ment with high concentrations of salt and deter-
gent and separated into two subspecies, NS1
and NS2, by chromatography on DEAE-cellu-
lose (14). The major NS subspecies present in
x~~~~
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FIG. 4. Recovery of 35S-labeled proteins associat-
ed with nucleocapsids by column chromatography.
Seven microliters of a 50-Fl reaction mixture was
treated with 0.5% NP-40 as described in the text and
analyzed by chromatography on a Bio-Gel A15M
agarose column. Samples (35 ,ul) of each of the 1.2-ml
fractions were assayed for TCA-precipitable radioac-
tivity. The arrow denotes the position at which marker
nucleocapsids elute.
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FIG. 5. Identification of "S-labeled proteins asso-
ciated with nucleocapsids. Seven microliters of a
standard reaction mixture was treated with 0.5% NP-
40 (lane 2), 0.43 M NaCl (lane 3), or 0.72 M NaCl (lane
4) and Triton X-100, and nucleocapsids were recov-
ered by chromatography on a Bio-Gel A1SM agarose
column. Fractions containing "S-labeled proteins as-
sociated with nucleocapsids were analyzed by electro-
phoresis on 10%o polyacrylamide gels containing SDS.
Lane 1 is a sample of the unfractionated reaction
mixture. The proteins of lane 4 were subjected to
electrophoresis on a gel separate from that shown in
lanes 1, 2, and 3. The identification of proteins in lane
4 was determined by coelectrophoresis of a sample of
the unfractionated reaction mixture in a parallel lane;
nucleocapsid-associated M protein comigrated exactly
with marker M protein in both gels.
smaller than the NS2 protein peak, representing
less than 10% of the amount of NS2 protein
present. In summary, these results indicate that
the NS2 subspecies, which is the predominant
form of NS protein associated with virion nu-
cleocapsids, is produced in vitro and is the major
form of NS protein found in association with
nucleocapsids isolated from the replication sys-
tem.
The proteins NS1 and NS2, when isolated
from virion nucleocapsids, can each be resolved
into two electrophoretically distinct forms, i.e.,
NStop and NSbottom, on polyacrylamide gels con-
taining urea and SDS (14). To test for the
presence of NS,Op and NSbottom components
with nucleocapsids from the replication system,
35S-labeled proteins associated with nucleocap-
sids were electrophoresed on 10% polyacryl-
amide gels containing 7 M urea and 0.1% SDS.
As seen in Fig. 7, both NStop (NST) and NSbottom
(NSB) are present. Since greater than 90% of the
NS protein associated with the nucleocapsids
from the replication system was NS2, both
NStop and NSbottom are derived from the NS2
subspecies.
Stability of the association of 35S-labeled pro-
tein with nucleocapsids. The stability of the asso-
ciation of 35S-labeled proteins with nucleocap-
sids in the replication system was compared to
virion nucleocapsids is NS2, shown to be the
more active species in supporting VSV RNA
synthesis in reconstituted in vitro transcription
reactions (14). The composition of the 35S-la-
beled NS protein, which associates with nucleo-
capsids in this replication system, was assayed
in the following manner. "S-labeled nucleocap-
sids from reaction mixtures of the replication
system were separated from soluble components
by ultracentrifugation, resuspended, incubated
in the presence of 0.72 M NaCl and Triton X-100
to release NS proteins, and pelleted again by
ultracentrifugation. The NS-containing supema-
tant was diluted with 10 mM Tris-hydrochloride
(pH 7.2) to a final concentration of less than 0.1
M NaCl and chromatographed on a phosphocel-
lulose column. Afterwards, the flow-through
fraction which contained NS protein was applied
to a DEAE-cellulose column and eluted with an
NaCl gradient. The chromatographic profile of a
representative experiment is shown in Fig. 6. In
this experiment, two peaks of nucleocapsid-
associated 35S-labeled NS protein were detected
by DEAE-cellulose chromatography. The peaks
were identified as NS1 and NS2 protein based
on the coelution of the second peak with 32p-
labeled NS2 protein dissociated from intact viri-






FIG. 6. DEAE column chromatography of "S-la-
beled NS protein associated with nucleocapsids. "S-
labeled NS protein was dissociated from nucleocap-
sids as described in the text. "S-labeled NS was
fractionated by chromatography on a phosphocellu-
lose column, and the flow-through fractions were
applied to a DEAE column. NS protein was eluted
with a linear gradient of 0.22 to 0.35 M NaCl in DEAE
column buffer. The positions of NS1 and NS2 were
determined by coelution of the "S-labeled NS protein
with a 32P-labeled NS protein marker obtained from
virions.
J. VIROL.




FIG. 7. Electrophoresis of 3"S-labeled proteins as-
sociated with nucleocapsids on polyacrylamide gels
containing urea and SDS. Seven microliters of a
reaction mixture was treated with 0.5% NP-40 and
chromatographed on a Bio-Gel A15M column. Nu-
cleocapsid-containing fractions were analyzed by elec-
trophoresis on a 10% polyacrylamide gel containing 7
M urea and 0.1% SDS. NST, NStOp; NSB, NSbttOm.
that of the protein components of virion nucleo-
capsids. Previous work has shown that certain
proteins of vesicular stomatitis virions can be
selectively removed by treatment with various
concentrations of salt in conjunction with the
detergent Triton X-100. Low concentrations of
salt remove the viral membrane proteins M and
G, but do not remove the N, NS, or L proteins
or affect the ability of the nucleocapsid to syn-
thesize RNA (21). Treatment with high concen-
trations of salt causes the loss of NS and L
proteins from the nucleocapsids, and hence
these nucleocapsids lose their ability to synthe-
size RNA (9).
To determine whether the 35S-labeled nucleo-
capsids produced in the in vitro system had
stability characteristics similar to those of viri-
ons, these structures were treated with either
low (0.43 M) or high (0.72 M) salt concentrations
and Triton X-100 for 45 min at 37°C. After
incubation, the structures were recovered by
chromatography on Bio-Gel A15M columns.
The 35S-labeled proteins which remained associ-
ated with the nucleocapsids after treatment with
low or high salt concentrations were analyzed by
electrophoresis on 10%0 polyacrylamide gels.
The data presented in Fig. 5 show that 35S-
labeled N, NS, L, and M proteins remained
associated with nucleocapsids treated with low
concentrations of salt. In contrast, only 35S-
labeled N and M proteins remained associated
with nucleocapsids subjected to high concentra-
tions of salt. Furthermore, even upon a second
treatment with high concentrations of salt, some
35S-labeled M protein remained associated with
these nucleocapsids (data not shown). Thus,
these data demonstrate that the nucleocapsid
proteins L, NS, and N synthesized in the in vitro
replication system associate into nucleocapsid
structures that have a degree of stability that
mimicks that of virion nucleocapsids. In addi-
tion, the data presented here show that a small
amount of M protein remains stably associated
with the nucleocapsids after salt treatment.
Molar ratios of nucleocapsid-associated pro-
teins. The molar ratios of 5S-labeled proteins
associated with nucleocapsids were determined
by densitometric scanning of fluorograms pro-
duced from polyacrylamide gels. The intensities
of the bands on the fluorogram representing 35S-
labeled N, NS, and M protein were corrected for
the number of constituent methionine residues
as reported by Rose and Gallione (24) and Gal-
lione et al. (10). Since the number of methionine
residues contained within the L protein is not
known, the molar ratio of this protein could not
be determined accurately by radiolabeling with
[35S]methionine. To estimate the number of L
proteins that had associated with the nucleocap-
sids synthesized in vitro, we assumed that 1%
(or 19) of the amino acid residues within the L
protein were methionine residues.
Table 1 shows the molar ratios of 35S-labeled
N, NS, M, and L protein associated with nucleo-
capsids isolated by column chromatography af-
TABLE 1. Molar ratio of "5S-labeled nucleocapsid
proteins relative to labeled N proteina
Nucleocapsid Molar ratiob
treatment NS N M LC
Control (0.5% 350 1,000 10 2
NP-40)
Low salt (0.43 250 1,000 3 2
M NaCl)
High salt (0.72 0 1,000 2 0
M NaCl)
Total soluble 1,700 1,000d 170 8
protein
a Nucleocapsids were recovered from the replica-
tion system by molecular exclusion column chroma-
tography after treatment with NP-40 or NaCl and
Triton X-100. "S-labeled proteins were identified by
electrophoresis on 10% polyacrylamide gels and quan-
titated by scanning fluorograms produced from the
gels.
b Ratios were corrected for numbers of methionines
contained in each protein (except L) as determined by
Rose and Gallione (24) and Gallione et al. (10). The
amino-terminal methionine was assumed to be re-
moved from the mature proteins and was not included
in the total methionine residues calculated for each
viral protein.
c L protein was assumed to contain 19 methionine
residues.
d To facilitate comparison of molar ratios of proteins
bound to nucleocapsids with total soluble proteins, all
values were adjusted relative to 1,000 N molecules. Of
the total N protein synthesized in vitro, 50% or less
associated into nucleocapsids.
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ter treatment with 0.5% NP-40 or Triton X-100
and either low or high concentrations of salt as
compared to the molar ratio of the proteins
synthesized by the system. The molar ratios
shown here for nucleocapsids before the salt
treatment are similar to those reported for viri-
ons and indicate de novo assembly of nucleocap-
sids from newly synthesized proteins. The molar
ratios of 35S-labeled protein (N:NS:M:L) associ-
ated with nucleocapsids treated under low salt
conditions showed that this treatment resulted in
the dissociation of a significant amount of NS
protein (approximately 100 molecules per 1,000
N protein molecules) that had remained associ-
ated with nucleocapsids treated with only the
detergent NP-40. From the molar ratio of 35S-
labeled protein associated with nucleocapsids
treated under high salt conditions, it is evident
that for this experiment, the treatment resulted
in the disassociation of essentially all NS and L
protein from the nucleocapsids. However, it
should be noted that in some cases up to 150 35S-
labeled NS molecules per 1,000 N protein mole-
cules remained associated with the nucleocap-
sids, even after this same treatment. These data
also show that even upon high salt treatment of
the nucleocapsids from the replication system, a
small population of M protein, representing ap-
proximately 2 molecules per 1,000 N protein
molecules, remained stably bound to the VSV
nucleocapsids found in our replication system.
DISCUSSION
We have developed a cell-free system which
supports VSV RNA replication as a function of
the level of viral protein synthesis (6, 7). The
products of RNA replication in this system
banded in CsCl and were partially resistant to
nuclease digestion, suggesting that the newly
synthesized RNAs were associated with protein.
For these reasons, we investigated the possibili-
ty that viral proteins and RNA synthesized in
this system could associate. Results presented in
this communication show that VSV proteins
synthesized in vitro concurrently with genomic
RNA assembled into structures that (i) banded
in CsCl gradients or eluted from molecular ex-
clusion columns at the same position as nucleo-
capsids, (ii) contained the viral proteins L, NS,
and N, and (iii) had the same stability as virion
nucleocapsids to salt treatment. Together with
our previous work (7), these data provide evi-
dence that nucleocapsids are assembled from
VSV proteins and genomic RNA synthesized
concurrently in vitro. Additional support for de
novo nucleocapsid formation comes from ex-
periments in our laboratory which demonstrate
that the association of viral proteins into nucleo-
capsids by the replication system is dependent
on VSV RNA synthesis; i.e., newly synthesized
proteins do not associate with input nucleocap-
sid templates in the absence of RNA synthesis
(J. T. Patton, N. L. Davis, and G. W. Wertz,
manuscript in preparation).
In the studies reported here, we analyzed the
association of VSV proteins into nucleocapsids
by the use of molecular exclusion column chro-
matography to separate nucleocapsids from non-
associated proteins. Previous studies by Hill et
al. (11) of the assembly of nucleocapsid-like
structures in vitro demonstrated that these
structures contained N protein but were unable
to show the presence ofNS and L proteins, both
components of intracellular nucleocapsids syn-
thesized in vivo (25). This probably resulted
from the use of CsCl gradients to isolate these
structures, a method known to dissociate NS
and L proteins from nucleocapsids (18). The
molecular exclusion technique used here en-
abled us to isolate intact nucleocapsids pro-
duced in vitro without the loss of associated
viral proteins. By using this technique, we dem-
onstrated that the newly synthesized VSV pro-
teins N, NS, and L, all necessary components of
functional nucleocapsids, did assemble into
structures that have the stability characteristics
and protein components of virion nucleocapsids.
We are currently investigating whether or not
these viral proteins synthesized in vitro are
functional with respect to enzymatic activity.
The molar ratio of 35S-labeled N, NS, and L
proteins making up the nucleocapsids assembled
in our replication system was 1,000:350:2
(N:NS:L) (Table 1). Previously, Mellon and
Emerson (16) estimated the molar ratio of N to
NS to L for intact virions to be 2,000:267:131
based on a molecular weight of NS protein of
40,000. When this ratio is adjusted for the cor-
rect molecular weight of NS protein as deter-
mined recently from sequence analysis (25,110
[10]), this value becomes 2,000:425:131 or
1,000:217:65. Thus, these data show that more
NS molecules are associated with the nucleo-
capsids assembled in our system than with viri-
ons, as reported by Mellon and Emerson (16).
This is in agreement with work by Clinton et al.
(4) and Bishop and Smith (2), which show that
more NS protein is associated with intracellular
nucleocapsids synthesized in vivo than with
virions. Furthermore, Clinton et al. (4) have
shown that a fraction of NS protein contained
within virions is dissociated by treatment of
these particles with 1% NP-40. Since we routine-
ly treat nucleocapsids synthesized in our replica-
tion system with 0.5% NP-40 before column
chromatography, it is possible that we have
underestimated the relative amount of the NS
protein associated with the nucleocapsids syn-
thesized in vitro. These data taken together
suggest that some amount of the NS protein
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associated with intracellular nucleocapsids may
be dissociated during some stage of virion as-
sembly. It is interesting to note that a large pool
of soluble NS protein was synthesized by the
replication system (Table 1) and that only a
small proportion of it associated with nucleocap-
sids. This is similar to the situation in infected
cells, where a large pool of free NS protein is
found (12, 26). The function of the pool of NS
protein is unknown.
Analysis of the newly synthesized NS protein
associated with nucleocapsids showed that it
was predominantly of the NS2 subspecies (14).
Kingsford and Emerson (14) have shown that
NS2 is also the predominant form of NS protein
associated with virion nucleocapsids and that it
is the more active subspecies of NS protein in
promoting viral transcription in vitro. Thus, it is
likely that the nucleocapsids assembled in the
replication system are capable of binding L
protein to produce an enzymatically active tem-
plate. The nucleocapsids assembled in the in
vitro system, however, had fewer molecules of
associated L protein than reported for the molar
ratio of proteins making up virion nucleocapsids
(2). To a large extent, this is due to the small
numbers of L protein made by the replication
system (Table 1); efficient synthesis of the large
L protein (190,000 daltons) in vitro is difficult to
achieve.
In addition to the nucleocapsid proteins N,
NS, and L, data presented here show the associ-
ation of a small number of newly synthesized M
protein molecules with nucleocapsids. Previous
work by Hsu et al. (12) indicates that a small
amount of M protein may also be associated
with intracellular nucleocapsids from infected
cells. These findings are of interest because of
recent studies indicating a possible regulatory
function for M protein. Results from experi-
ments with VSV class III mutants have demon-
strated the involvement of M protein in the
regulation of viral RNA synthesis (5). Further
studies have shown that high concentrations of
purified M protein can partially inhibit RNA
synthesis by VSV virion nucleocapsids in vitro
and that the level of inhibition decreases with
increasing salt concentration in vitro (3, 23, 29).
Although greater than 0.2 ,.g of soluble, non-
membrane-associated M protein was synthe-
sized per ml under physiological salt conditions
in our replication system, less than 1% of the M
protein made associated with nucleocapsids.
The molar ratio ofN to M found for the nucleo-
capsids synthesized by the replication system
was 1,000:10, in contrast to approximately
1,000:2,000 reported for virions (2). These re-
sults show that non-membrane-associated M
protein such as that present in our in vitro
system does not interact readily with non-mem-
brane-bound nucleocapsids. This may reflect the
situation in VSV-infected cells, for which it is
known that the plasma membrane rapidly accu-
mulates newly synthesized M protein (17) and is
the site of nucleocapsid budding. Thus, the
membrane is likely the predominant site in vivo
where M protein interacts with the intracellular
nucleocapsid. Alternatively, the finding that
only a small percentage of the M protein made in
our system bound to nucleocapsids could be
explained by differences in the conformation or
solubility of M protein made in vitro compared
to M protein stripped from nucleocapsids, or by
the difference between extracellular nucleocap-
sids, which are prepared with salt and detergent
treatment, and the intracellular nucleocapsids
used here, which were prepared without such
treatments.
In summary, the data reported above show
that the concurrent synthesis of VSV negative-
stranded RNA and the five viral proteins in a
defined cell-free system resulted in the assembly
of VSV proteins into structures that have the
stability characteristics and protein components
of nucleocapsids produced in infected cells. We
are currently investigating which of the VSV
proteins are responsible for VSV RNA replica-
tion.
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